[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100497171":3},{"organization":4,"armGroups":7,"interventions":20,"overallOfficials":34,"centralContacts":38,"locations":49,"responsibleParty":67,"collaborators":43,"id":70,"slug":43,"hasResults":71,"nctId":72,"briefTitle":73,"officialTitle":74,"acronym":75,"eligibilityCriteria":76,"healthyVolunteers":77,"sex":78,"minAge":79,"maxAge":80,"enrollmentInfo":81,"targetDuration":43,"studyType":84,"phases":85,"briefSummary":87,"conditions":88,"keywords":90,"overallStatus":51,"whyStopped":43,"lastUpdateSubmitDate":95,"lastUpdatePostDateStruct":96,"startDateStruct":99,"completionDateStruct":101,"leadSponsor":103,"locationsCount":104},{"fullName":5,"class":6},"Tongji Hospital","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"fecal microbiota transplantation","ACTIVE_COMPARATOR","Fecal microbiota transplantation routes include the upper digestive tract, lower digestive tract, or oral fecal microbiota transplantation capsules",[13],"Biological: FMT",{"label":15,"type":16,"description":17,"interventionNames":18},"Conventional drug intervention","SHAM_COMPARATOR","Conventional drugs include: probiotics and omeprazole, and cyproheptadine and moxapride.",[19],"Drug: Conventional drugs",[21,27],{"type":22,"name":23,"description":24,"armGroupLabels":25,"otherNames":26},"BIOLOGICAL","FMT","FMT is a technique in which intestinal microbiota are transferred from a healthy screened donor to a patient, with the goal being to introduce or restore a stable microbial community in the gut. FMT was given 1-3courses, 3-6 times per courses",[9],[9],{"type":28,"name":29,"description":30,"armGroupLabels":31,"otherNames":32},"DRUG","Conventional drugs","Conventional drugs include probiotics and omeprazole, and cyproheptadine and moxapride",[15],[33],"cyproheptadine",[35],{"name":36,"affiliation":5,"role":37},"Zhihua Huang","STUDY_DIRECTOR",[39,45],{"name":40,"role":41,"phone":42,"phoneExt":43,"email":44},"Biao Zou, MD","CONTACT","15871365900",null,"464021552@qq.com",{"name":46,"role":41,"phone":47,"phoneExt":43,"email":48},"Sainan Shu, MD, PhD","13886011908","shusainan@163.com",[50],{"facility":5,"status":51,"city":52,"state":43,"zip":53,"country":54,"cosmosGeoPoint":55,"geoPoint":60,"contacts":61},"RECRUITING","Wuhan","430030","China",{"type":56,"coordinates":57},"Point",[58,59],114.26667,30.58333,{"lat":59,"lon":58},[62,64],{"name":63,"role":41,"phone":47,"phoneExt":43,"email":48},"Sainan Shu, professor",{"name":65,"role":41,"phone":66,"phoneExt":43,"email":44},"Biao Zou","+8685726753",{"type":68,"investigatorFullName":65,"investigatorTitle":69,"investigatorAffiliation":5,"oldNameTitle":43,"oldOrganization":43},"SPONSOR_INVESTIGATOR","associate professor","100497171",false,"NCT05753774","Effect of Fecal Microbiota Transplantation (FMT) in Pediatric Functional Gastrointestinal Disorders","Efficacy and Safety of Fecal Microbiota Transplantation in the Treatment of Functional Gastrointestinal Disorders in Children","FGIDs","Inclusion Criteria:\n\n* The diagnosis and classification of patients with FGIDs were in accordance with the ROME IV criteria for children\n\nExclusion Criteria:\n\n* organic gastrointestinal disease (as established by medical history, blood routine, biochemistry, c-reaction protein, erythrocyte sedimentation rate, and fecal routine examinations.)\n* other chronic disease\n* growth failure",true,"ALL","1 Year","15 Years",{"count":82,"type":83},100,"ESTIMATED","INTERVENTIONAL",[86],"NA","Safety and efficacy of FMT in Pediatric Functional Gastrointestinal Disorders",[89],"Functional Gastrointestinal Disorders",[91,92,93,94],"Functional Gastrointestinal Disorders;","FMT;","Safety; efficacy","efficacy","2025-09-03",{"date":97,"type":98},"2025-09-10","ACTUAL",{"date":100,"type":98},"2022-08-01",{"date":102,"type":83},"2026-08-01",{"name":65,"class":6},1]